Tirzepatide Approvals: Glycemic control for those with type 2 diabetes
This is an insulin-independent glucose uptake pathway
Currently available across the United States, Hers focuses on convenience and speed, helping patients get started faster than most traditional programs
Christensen MB, Lund AB, Jrgensen NR, Holst JJ, Vilsbll T, Knop FK (2020) Glucose-dependent insulinotropic polypeptide (GIP) reduces bone resorption in patients with type 2 diabetes
Class B GPCRs typically bind their peptide ligands through a mechanism known as the two-domain model, in which ECD binds to the C-terminal helix of GLP-1, and the transmembrane domain (TMD) binds to the N-terminal region of GLP-1 (3, 4, 5)
Reach out to us at 1-647-576-2076 and start moving toward your health goals today